Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621592 · ClinicalTrials.gov registry record · NA
VLU Dressing Study
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03621592 is a NA study that has completed, run by University of Miami. The registered enrollment target is 31 participants.
The verdict
NCT03621592, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The goal of the study is to investigate the effectiveness of Cutimed Sorbact (Study Device) in modifying bacterial load in venous leg ulcers (VLU).
Interventions
- DEVICE Cutimed® Sorbact®
- DEVICE Acticoat®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-08-22 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621592
The ClinicalTrials.gov registry entry for NCT03621592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cutimed® Sorbact® is the first listed.
NCT03621592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621592 about?
NCT03621592 is a clinical study titled "VLU Dressing Study". The goal of the study is to investigate the effectiveness of Cutimed Sorbact (Study Device) in modifying bacterial load in venous leg ulcers (VLU).
What is the current status of trial NCT03621592?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2018-08-22. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT03621592?
The interventions under investigation include: Cutimed® Sorbact® (DEVICE), Acticoat® (DEVICE).
Who is sponsoring clinical trial NCT03621592?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.